DDrare: Database of Drug Development for Rare Diseases

Tamibarotene (DrugBank: Tamibarotene)

2 diseases

ID	Disease name (Link within this page)	Number of trials
26	HTLV-1-associated myelopathy	1
96	Crohn disease	1

26. HTLV-1-associated myelopathy [ 26 clinical trials, 46 drugs, (DrugBank: 27 drugs), 37 drug target genes, 123 drug target pathways]

Searched query = "HTLV-1-associated myelopathy", "Tropical spastic paraparesis", "HTLV-1", "HTLV-I-associated myelopathy"
The queries were searched in Public_title, Scientific_title, and Condition. Export date: 03/15/2021. Trials are sorted by Date_enrollment from most recent to oldest in the table.

1 / 26 trial found

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	NCT01343355 (ClinicalTrials.gov)	January 2011	25/4/2011	Efficacy and Safety of Tamibarotene(AM80H) for HTLV-1 Associated Myelopathy/ Tropical Spastic Paraparesis (HAM/TSP)	Open-Label, Exploratory Study of the Efficacy and Safety of Tamibarotene(AM80H) for HTLV-1 Associated Myelopathy/ Tropical Spastic Paraparesis (HAM/TSP)	HTLV-I-Associated Myelopathy	Drug: Tamibarotene	St. Marianna University School of Medicine	NULL	Active, not recruiting	30 Years	75 Years	Both	15	Phase 2;Phase 3	Japan

96. Crohn disease [ 2,209 clinical trials, 1,276 drugs, (DrugBank: 240 drugs), 166 drug target genes, 210 drug target pathways]

Searched query = "Crohn disease", "Terminal ileitis"
The queries were searched in Public_title, Scientific_title, and Condition. Export date: 03/15/2021. Trials are sorted by Date_enrollment from most recent to oldest in the table.

1 / 2,209 trial found

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	NCT00417391 (ClinicalTrials.gov)	December 2006	28/12/2006	Phase II Study of RR110 in Patients With Active Crohn's Disease	Phase II Study of RR110 in Patients With Active Crohn's Disease	Crohn's Disease	Drug: RR110 (Tamibarotene)	R&R Inc.	NULL	Completed	20 Years	N/A	Both	24	Phase 2	Japan